Showing results (1-10 of 375) with videos related to
Sort By:
Pageof 38
Cancer Discovery|February 20, 2014
Improving the efficacy of chemoradiation with targeted agentsMeredith A Morgan, Leslie A Parsels, Jonathan Maybaum, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Improving gemcitabine-mediated radiosensitization using molecularly targeted therapy: a reviewMeredith A Morgan, Leslie A Parsels, Jonathan Maybaum, et al.Cell Cycle (Georgetown, Tex.)|August 26, 2006
The relationship of premature mitosis to cytotoxicity in response to checkpoint abrogation and antimetabolite treatmentMeredith A Morgan, Leslie A Parsels, Joshua D Parsels, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2010
Bayesian hierarchical changepoint methods in modeling the tumor growth profiles in xenograft experimentsLili Zhao, Meredith A Morgan, Leslie A Parsels, et al.Cell Cycle (Georgetown, Tex.)|June 14, 2018
The contribution of DNA replication stress marked by high-intensity, pan-nuclear γH2AX staining to chemosensitization by CHK1 and WEE1 inhibitorsLeslie A Parsels, Joshua D Parsels, Daria M Tanska, et al.Cancer Research|August 3, 2005
Role of checkpoint kinase 1 in preventing premature mitosis in response to gemcitabineMeredith A Morgan, Leslie A Parsels, Joshua D Parsels, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
The combination of epidermal growth factor receptor inhibitors with gemcitabine and radiation in pancreatic cancerMeredith A Morgan, Leslie A Parsels, Laura E Kollar, et al.Cell Cycle (Georgetown, Tex.)|February 19, 2016
Dissociation of gemcitabine chemosensitization by CHK1 inhibition from cell cycle checkpoint abrogation and aberrant mitotic entryLeslie A Parsels, Daria M Tanska, Joshua D Parsels, et al.Cell Cycle (Georgetown, Tex.)|December 3, 2011
Selective radiosensitization of p53 mutant pancreatic cancer cells by combined inhibition of Chk1 and PARP1Sean Vance, Erqi Liu, Lili Zhao, et al.Neoplasia (New York, N.Y.)|July 13, 2012
Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibitionVenkatasubbaiah A Venkatesha, Leslie A Parsels, Joshua D Parsels, et al.Pageof 38